Mobile Menu

Search Results

Search results for: Drug Reaction

Genome UK: The future of healthcare

Genome UK The UK has launched its new National Genomic Healthcare Strategy, with the goal of cementing its status as […]

The potential role of PGx in managing experimental therapies for COVID-19

Since the outbreak of the COVID-19 pandemic, many clinical trials have been launched to help understand the virus and any […]

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

Genomics Week in Brief: Week ending 6th October

Welcome back to Week in Brief, your weekly rundown of the latest and greatest news in the genomics world. Let’s […]

The Festival of Genomics and Biodata: An Interview with Fei Chen, Broad Institute of MIT and Harvard

At the Festival of Genomics and Biodata, we are lucky enough to be joined by some of the biggest names […]

Enzyme ping-pong provides pointers for new antibiotics

‘Enzyme ping-pong provides pointers for new antibiotics’ – Written by Charlotte Harrison, Science Writer  The specialized lipoproteins in bacteria are […]

Unlocking the future: where is gene editing going next?

As advancements in genetic technologies accelerate at an astonishing pace, the potential for gene editing to transform our world becomes […]

Gene-editing: A Controversial Legacy

The field of genetics is a relatively young science, beginning with Gregor Mendel’s studies on the inheritance of traits in […]

Genomics week in brief: Week ending 11th March

Check out the latest Genomics Week in Brief – full of intriguing news and research from the genomics space! Top […]

A Spotlight On: Rare Disease – Marshall Summar, Director of the Rare Disease Institute at the Children’s National Hospital

Marshall Summar is Director of the Rare Disease Institute at the Children’s National Hospital. He runs the genetics and metabolism […]